Company research
ARTIVION, INC.
CIK 784199Updated Sep 27, 2026
SecuritiesAORT · NYSE · equityCRY · NASDAQ · etf
Name history
CRYOLIFE INC · through Jan 6, 2022
AORT price & chart
Loading TradingView…
NYSE:AORT on TradingView ↗About the company
Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons’ most difficult challenges in treating patients with aortic diseases. Artivion’s four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www. Artivion.com.
In the news
Artivion Reports Third Quarter 2025 Financial Results News provided by Artivion, Inc. Nov 06, 2025, 16:05 ET Share this article Share to X Share this article Share to X Third Quarter Highlights: Achieved revenue of $113.4 million in the third quarter of 2025 versus $95.8 million in the third quarter ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 884,796,000Source | 789,101,000Source | 792,397,000Source | 762,798,000Source |
| Property, Plant and Equipment, NetUSD | 64,988,000Source | 36,403,000Source | — | 38,674,000Source |
| GoodwillUSD | 254,091,000Source | 240,958,000Source | 247,337,000Source | 243,631,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 64,908,000Source | 53,463,000Source | 58,940,000Source | 39,351,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 89,758,000Source | 79,462,000Source | 71,796,000Source | 61,820,000Source |
| Inventory, NetUSD | 92,427,000Source | 79,766,000Source | 81,976,000Source | 74,478,000Source |
| Assets, CurrentUSD | 358,082,000Source | 290,080,000Source | 280,668,000Source | 247,334,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 42,537,000Source | 19,257,000Source | 15,810,000Source | 17,550,000Source |
| Operating Lease, Right-of-Use AssetUSD | 34,701,000Source | 39,726,000Source | 43,822,000Source | 41,859,000Source |
| Other Assets, NoncurrentUSD | 15,238,000Source | 24,483,000Source | 8,894,000Source | 7,339,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 436,564,000Source | 512,901,000Source | 510,617,000Source | 478,469,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 493,000Source | 434,000Source | 426,000Source | 418,000Source |
| Retained Earnings (Accumulated Deficit)USD | -51,498,000Source | -61,266,000Source | -47,907,000Source | -17,217,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -2,719,000Source | -24,927,000Source | -12,010,000Source | -21,609,000Source |
| Stockholders' Equity Attributable to ParentUSD | 448,232,000Source | 276,200,000Source | 281,780,000Source | 284,329,000Source |
| Additional Paid in Capital, Common StockUSD | 516,604,000Source | 376,607,000Source | 355,919,000Source | 337,385,000Source |
| Liabilities and EquityUSD | 884,796,000Source | 789,101,000Source | 792,397,000Source | 762,798,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 101,556,000Source | 66,823,000Source | 57,862,000Source | 49,675,000Source |
| Operating Lease, Liability, CurrentUSD | 4,649,000Source | 4,489,000Source | 3,395,000Source | 3,308,000Source |
| Accounts Payable, CurrentUSD | 16,042,000Source | 17,971,000Source | 13,318,000Source | 12,004,000Source |
| Operating Lease, Liability, NoncurrentUSD | 34,427,000Source | 39,988,000Source | 43,977,000Source | 41,257,000Source |
| Deferred Income Tax Liabilities, NetUSD | 24,308,000Source | 20,183,000Source | 21,851,000Source | 24,499,000Source |
| Other Liabilities, NoncurrentUSD | 9,107,000Source | 8,065,000Source | 7,341,000Source | 7,027,000Source |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 16,447,000Source | 11,834,000Source | 12,732,000Source | 12,374,000Source |
| Deferred Tax Liabilities, NetUSD | 23,107,000Source | 19,115,000Source | 20,764,000Source | 23,185,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 215,114,000Source | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 0Source | 195,000Source | 1,451,000Source | 1,608,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 215,114,000Source | 314,152,000Source | 305,531,000Source | 306,499,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 22,458,000Source | 24,205,000Source | 23,076,000Source | 22,442,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 24,385,000Source | 14,242,000Source | 14,422,000Source | 12,344,000Source |
| Deferred Income Tax Expense (Benefit)USD | 37,000Source | -1,511,000Source | -1,324,000Source | -885,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 39,880,000Source | 22,236,000Source | 18,825,000Source | -5,153,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | 0Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -42,041,000Source | -28,188,000Source | -502,000Source | -10,715,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | — | 2,322,000Source | 0Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 39,041,000Source | 11,188,000Source | 7,430,000Source | 9,016,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 0Source | 0Source | 559,000Source | 1,795,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 11,282,000Source | 2,203,000Source | 865,000Source | -1,639,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | -699,000Source | -623,000Source | -537,000Source | -459,000Source |
| Repayments of Long-term DebtUSD | 210,000Source | 211,831,000Source | 2,772,000Source | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 11,445,000Source | -5,477,000Source | 19,589,000Source | -15,659,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 64,908,000Source | 53,463,000Source | 58,940,000Source | 39,351,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Income Taxes Paid, NetUSD | 2,543,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 2,324,000Source | -1,728,000Source | 401,000Source | 1,848,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 3,700,000Source | — | — | — |
| Amortization of Intangible AssetsUSD | 13,775,000Source | 15,855,000Source | 15,198,000Source | 15,310,000Source |
| DepreciationUSD | 8,683,000Source | 8,350,000Source | 7,878,000Source | 7,132,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 7,200,000Source | -5,400,000Source | 2,100,000Source | -3,100,000Source |
| Gain (Loss) on Disposition of AssetsUSD | 7,000,000Source | 0Source | 14,250,000Source | — |
| Gain (Loss) on Disposition of BusinessUSD | — | — | — | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | -3,669,000Source | — | — |
| GoodwillUSD | 254,091,000Source | 240,958,000Source | 247,337,000Source | 243,631,000Source |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 5,012,000Source | 5,845,000Source | 9,104,000Source | 4,208,000Source |
| InterestExpenseNonoperatingUSD | 26,582,000Source | 34,277,000Source | — | — |
| Inventory Write-downUSD | 3,300,000Source | 3,800,000Source | 4,400,000Source | 4,000,000Source |
| Investment Income, InterestUSD | 763,000Source | 1,467,000Source | 1,077,000Source | 147,000Source |
| Net Income (Loss) Attributable to ParentUSD | 9,768,000Source | -13,359,000Source | -30,690,000Source | -19,192,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 9,757,000Source | -13,335,000Source | -30,567,000Source | -19,094,000Source |
| Operating ExpensesUSD | 257,482,000Source | 209,907,000Source | 237,684,000Source | 196,322,000Source |
| Other Nonoperating Income (Expense)USD | 9,518,000Source | -9,909,000Source | -3,106,000Source | -3,108,000Source |
| Proceeds from Issuance of Common StockUSD | 13,074,000Source | 5,728,000Source | 3,955,000Source | 3,368,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | 184,000,000Source | — | — |
| Realized Investment Gains (Losses)USD | 0Source | 0Source | 0Source | 0Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | 24,385,000Source | 14,968,000Source | 15,146,000Source | 12,942,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 441,330,000Source | 388,537,000Source | 354,004,000Source | 313,789,000Source |
| Cost of RevenueUSD | 157,103,000Source | 139,756,000Source | 124,828,000Source | 111,266,000Source |
| Selling, General and Administrative ExpenseUSD | 226,491,000Source | 181,455,000Source | 208,977,000Source | 157,443,000Source |
| Operating Income (Loss)USD | 33,745,000Source | 38,874,000Source | 5,742,000Source | 6,201,000Source |
| Other Nonoperating Income (Expense)USD | 9,518,000Source | -9,909,000Source | -3,106,000Source | -3,108,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 14,780,000Source | -7,514,000Source | -21,586,000Source | -14,984,000Source |
| Income Tax Expense (Benefit)USD | 5,012,000Source | 5,845,000Source | 9,104,000Source | 4,208,000Source |
| Net Income (Loss) Attributable to ParentUSD | 9,768,000Source | -13,359,000Source | -30,690,000Source | -19,192,000Source |
| Earnings Per Share, BasicUSD per share | 0.22Source | -0.32Source | -0.75Source | -0.48Source |
| Earnings Per Share, DilutedUSD per share | 0.21Source | -0.32Source | -0.75Source | -0.48Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 45,335,000Source | 41,676,000Source | 40,743,000Source | 40,032,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 47,162,000Source | 41,676,000Source | 40,743,000Source | 40,032,000Source |
| Interest Expense (non-operating)USD | 26,582,000Source | 34,277,000Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 13,775,000Source | 15,855,000Source | 15,198,000Source | 15,310,000Source |
| Current Income Tax Expense (Benefit)USD | 4,975,000Source | 7,356,000Source | 10,428,000Source | 5,093,000Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 7,200,000Source | -5,400,000Source | 2,100,000Source | -3,100,000Source |
| Gross ProfitUSD | 284,227,000Source | 248,781,000Source | 229,176,000Source | 202,523,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 5,309,000Source | 4,559,000Source | -24,658,000Source | -13,798,000Source |
| Interest ExpenseUSD | — | — | 25,299,000Source | 18,224,000Source |
| Investment Income, InterestUSD | 763,000Source | 1,467,000Source | 1,077,000Source | 147,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 9,757,000Source | -13,335,000Source | -30,567,000Source | -19,094,000Source |
| Operating ExpensesUSD | 257,482,000Source | 209,907,000Source | 237,684,000Source | 196,322,000Source |
| Realized Investment Gains (Losses)USD | 0Source | 0Source | 0Source | 0Source |
| Research and Development ExpenseUSD | 30,991,000Source | 28,452,000Source | 28,707,000Source | 38,879,000Source |
| Share-based Payment Arrangement, Expensed and Capitalized, AmountUSD | 24,385,000Source | 14,968,000Source | 15,146,000Source | 12,942,000Source |
| Undistributed Earnings (Loss) Allocated to Participating Securities, BasicUSD | 11,000Source | -24,000Source | -123,000Source | -98,000Source |
Filing attachments
aort-2026x8k063026ex991.htm · 8-K · 2026-08-06
EX-99.1 2 aort-2026x8k063026ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Artivion Gilmartin Group LLC Lance A. Berry Brian Johnston Executive Vice President, Phone: 332-895-3222 Chief Operating Officer & investors@artivion.com Chief Financial Officer Phone: 770-419-3355 Artivion Reports Second Quarter 2026 Financial Results Second Quarter & Recent Business Highlights: • Achieved revenue of $125.8 mi…
Read attachment ↗aort-2026x8k051826ex991.htm · 8-K · 2026-05-18
EX-99.1 5 aort-2026x8k051826ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Artivion Gilmartin Group LLC Lance A. Berry Brian Johnston Executive Vice President, Phone: 332-895-3222 Chief Operating Officer & investors@artivion.com Chief Financial Officer Phone: 770-419-3355 Artivion Completes Acquisition of Endospan Ltd. ATLANTA, GA - (May 18, 2026) - Artivion, Inc. (NYSE: AORT), a leading cardiac and va…
Read attachment ↗aort-2026x8k033126ex991.htm · 8-K · 2026-05-07
EX-99.1 5 aort-2026x8k033126ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Artivion Gilmartin Group LLC Lance A. Berry Brian Johnston Executive Vice President, Phone: 332-895-3222 Chief Operating Officer & investors@artivion.com Chief Financial Officer Phone: 770-419-3355 Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan First Quarter & Recent Bu…
Read attachment ↗aort-2025x8k123125ex991.htm · 8-K · 2026-02-12
EX-99.1 2 aort-2025x8k123125ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Artivion Gilmartin Group LLC Lance A. Berry Brian Johnston / Laine Morgan Executive Vice President, Phone: 332-895-3222 Chief Operating Officer & investors@artivion.com Chief Financial Officer Phone: 770-419-3355 Artivion Reports Fourth Quarter and Full Year 2025 Financial Results Fourth Quarter Highlights: • GAAP revenue was $…
Read attachment ↗aort-2025x8k093025ex991.htm · 8-K · 2025-11-06
EX-99.1 2 aort-2025x8k093025ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Artivion Gilmartin Group LLC Lance A. Berry Brian Johnston Executive Vice President, Laine Morgan Chief Operating Officer & Phone: 332-895-3222 Chief Financial Officer investors@artivion.com Phone: 770-419-3355 Artivion Reports Third Quarter 2025 Financial Results Third Quarter Highlights: • Achieved revenue of $113.4 mi…
Read attachment ↗aort-2025x8k063025ex991.htm · 8-K · 2025-08-07
EX-99.1 2 aort-2025x8k063025ex991.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE Contacts: Artivion Gilmartin Group LLC Lance A. Berry Brian Johnston / Laine Morgan Executive Vice President & Phone: 332-895-3222 Chief Financial Officer investors@artivion.com Phone: 770-419-3355 Artivion Reports Second Quarter 2025 Financial Results Second Quarter Highlights: • Achieved revenue of $113.0 million in the second quart…
Read attachment ↗